BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6139829)

  • 1. Hypophysectomy-induced striatal hypersensitivity and mesolimbic hyposensitivity to apomorphine.
    Gordon JH
    Pharmacol Biochem Behav; 1983 Nov; 19(5):807-11. PubMed ID: 6139829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre- and postsynaptic neurochemical alterations following estrogen-induced striatal dopamine hypo- and hypersensitivity.
    Gordon JH; Perry KO
    Brain Res Bull; 1983 Apr; 10(4):425-8. PubMed ID: 6134572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypophysectomy induced hypersensitivity to dopamine: antagonism by estrogen.
    Perry KO; Diamond BI; Fields JZ; Gordon JH
    Brain Res; 1981 Dec; 226(1-2):211-9. PubMed ID: 7197571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of apomorphine-induced behaviour following chronic swim exercise in rats.
    Dey S; Singh RH
    Neuroreport; 1992 Jun; 3(6):497-500. PubMed ID: 1391756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens.
    Weissenborn R; Winn P
    Behav Brain Res; 1992 Nov; 51(2):127-37. PubMed ID: 1466779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mesolimbic system, denervation and the climbing response in the mouse.
    Costall B; Fortune DH; Naylor RJ; Nohria V
    Eur J Pharmacol; 1980 Aug; 66(2-3):207-15. PubMed ID: 6108225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
    Kudrin VS; Hetey L; Morgenshtern R; Raevskiĭ KS; Olssner W
    Farmakol Toksikol; 1987; 50(2):16-20. PubMed ID: 2884129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in amphetamine-induced locomotor activity and stereotypy after electrical stimulation of the nucleus accumbens and neostriatum.
    Kokkinidis L; Kirkby RD; McCarter BD; Borowski TB
    Life Sci; 1989; 44(9):633-41. PubMed ID: 2927262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA-dopamine interaction in substantia nigra and nucleus accumbens--relevance to behavioral stimulation and stereotyped behavior.
    Scheel-Krüger J; Arnt J; Braestrup C; Christensen AV; Cools AR; Magelund G
    Adv Biochem Psychopharmacol; 1978; 19():343-6. PubMed ID: 567933
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral and neurochemical modifications induced by apomorphine treatment.
    Piervincenzo P; Luciana G; Laura C; Giuseppe A
    Neurosci Lett; 1989 May; 100(1-3):265-70. PubMed ID: 2761776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kainic acid lesions of the striatum dissociate amphetamine and apomorphine stereotypy: similarities to Huntingdon's chorea.
    Mason ST; Sanberg PR; Fibiger HC
    Science; 1978 Jul; 201(4353):352-5. PubMed ID: 26976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kainic acid lesions of the striatum: behavioural sequalae similar to Huntington's chorea.
    Mason ST; Fibiger HC
    Brain Res; 1978 Oct; 155(2):313-29. PubMed ID: 28817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral demonstration of a reciprocal interaction between dopamine receptor subtypes in the mouse striatum: possible involvement of the striato-nigral pathway.
    Mandel RJ; Yurek DM; Randall PK
    Brain Res Bull; 1990 Aug; 25(2):285-92. PubMed ID: 2146002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist.
    Cameron DL; Crocker AD
    Neuroscience; 1989; 32(3):769-78. PubMed ID: 2601845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):53-61. PubMed ID: 1099605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity.
    Fields JZ; Wichlinski L; Drucker GE; Engh K; Gordon JH
    Pharmacol Biochem Behav; 1991 Dec; 40(4):881-6. PubMed ID: 1816575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity.
    Bevan P
    Neurosci Lett; 1983 Feb; 35(2):185-9. PubMed ID: 6222273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.